RV
Ratnakumari Vankadara
About Ratnakumari Vankadara
Data last updated:
Ratnakumari Vankadara is a Director at Vivier Pharma Private Limited (since 2021) and Director at Vivier Spaces Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Vivier Pharma Private Limited at ₹20.30 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jan 2021 | 2021 | ₹20.30 Cr (FY 2022) | Active | |
| Director | 06 Sep 2023 | 2023 | Active |
Board colleagues of Ratnakumari Vankadara
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sravani Kanamarlapudi | 09022649 | Vivier Pharma Private Limited , Vivier Spaces Private Limited | Director |
| Vasudeva Rao Vankadara | 07035050 | Vivier Pharma Private Limited , Vivier Spaces Private Limited | Director |
| Vijaya Kumar Vankadara | 09022648 | Vivier Pharma Private Limited , Vivier Spaces Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ratnakumari Vankadara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ratnakumari Vankadara
Ratnakumari Vankadara currently holds 2 directorships: Vivier Pharma Private Limited (Director, since 07 Jan 2021, revenue ₹20.30 Cr (FY 2022)); Vivier Spaces Private Limited (Director, since 06 Sep 2023).
Ratnakumari Vankadara was first appointed on 07 Jan 2021 as Director at Vivier Pharma Private Limited. The most recent appointment on record is 06 Sep 2023 at Vivier Spaces Private Limited.
The current boards of Ratnakumari Vankadara's companies include Sravani Kanamarlapudi (Vivier Pharma Private Limited), Vasudeva Rao Vankadara (Vivier Pharma Private Limited), Vijaya Kumar Vankadara (Vivier Pharma Private Limited).